Skip to content

Site Spotlight: With the COVID-19 Directive For Elective Medical Procedures, Clinical Research Is Grounded in Louisiana

Dr. Stone: Research has come to a halt. We were actively working on 20 clinical trials, but now we are only able to see patients in person who cannot be seen via telehealth, which has also been mandated by the State.

CRIO: Are you able to switch to virtual visits for clinical trials?

Dr. Stone: Only one sponsor has allowed us to discuss conmeds and conduct PROs over the phone presently, but virtual visits will not work for what study visits require. All of our studies require physical exams and imaging. In fact, most of our studies require a radiologic primary endpoint that cannot be collected if patients cannot come in. When patients are eventually able to return to the clinic, most data points will be out of window. Everyone understands that our hands are tied and we will do what we can though using telehealth.

CRIO: How are your sponsors maintaining oversight for ongoing trials?

Dr. Stone: We have received requests for remote monitoring, but most either want documents to be faxed or uploaded to Box after patient info has been redacted. We already have in place a system through CRIO, though that is far less labor intensive at this point. Since we are on eSource, everything is already available to the clinical research associates online. They are able to use the existing system that they are accustomed to already.

CRIO: What do you wish regulatory authorities would do more of?

Dr. Stone: Pointed communication. We are all in this together. Many of us are scrambling to meet the needs of a very fluid situation. The processes in place a week ago no longer meet the needs of today. Today’s processes will likely not meet the needs of tomorrow.

Everyone in the research world has been adversely affected by one aspect or another of the COVID-19 response.  Now is the time for us to pull together and find solutions that launch us into the next phase of clinical trial work shaping the future of what we all do.

– Marcus Stone, MD, Director of Clinical Research at the Spine Institute of Louisiana Foundation

CRIO: How do you think COVID will impact the future of clinical research?

Dr. Stone: There is going to be a trickle-down effect. Stalled enrollment and missed follow up visits will increase the time and cost of clinical trials. This will lead to a significant slowdown in new drug and device development. New treatments that could have come out in, say 2022, now might come out in 2023. Sponsors’ commercial business will be negatively impacted as well due to a sharp decline in healthcare utilization. Consequently, it is likely they will invest less in research and development in the near term. Undoubtedly, COVID-19 will have a significant long-term effect on health care in general. That said, in the clinical trial world we are used to adapting and will manage these trying times. I am certain we will come out on the other side of this stronger and better equipped.

by Maxine Lai Customer Success Manager at CRIO
Share this post
You may also find interesting
Explore our Blog
Running a Site

Ask Me Anything – Tools for Top Performing Sites

Kristen Bosse, Director of Product Development, is CRIO’s in-house product guru. In this Ask Me Anything, a CRIO expert roundup, Kristen discusses CRIO’s products, UX design and beta testing, and shares recommendations for sponsors looking to identify the best sites for their trials. What differentiates CRIO’s products from any other products on the market?  We...

Unlocking the Benefits of CRIO: eSource & eConsent Running a Site

Unlocking the Benefits of CRIO: eSource & eConsent

eConsent: The Benefits With the recent push toward Decentralized Clinical Trials, many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs investigators and patients these benefits: Removal of errors by ensuring completion of all fields Accuracy of date-times through...

In Big Diverse Corporate Office: Portrait of Beautiful Asian Manager Using Desktop Computer, Businesswoman Managing Company Operations, Analysing Statistics, Commerce Data, Marketing Plans. Running a Site

Data Blast from the Past: From Triplicate to eCRF

Jonathan Andrus, President & COO at CRIO, is an active thought-leader and presenter in the life sciences industry. He serves on the board and executive committee of the Society for Clinical Data Management (SCDM) and is co-lead with the Decentralized Trials and Research Alliance (DTRA) workstream initiative. The year was 1996 – the year that...